We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.76B
AUM Growth
+$499M
Cap. Flow
+$366M
Cap. Flow %
4.71%
Top 10 Hldgs %
15.72%
Holding
1,667
New
74
Increased
571
Reduced
929
Closed
86

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$48.8M
2
DOC icon
Healthpeak Properties
DOC
+$16.2M
3
CLX icon
Clorox
CLX
+$16.1M
4
BF.B icon
Brown-Forman Class B
BF.B
+$14.4M
5
HRL icon
Hormel Foods
HRL
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 13.27%
3 Financials 13.22%
4 Consumer Staples 11.59%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIN icon
876
First Financial Bankshares
FFIN
$4.94B
$617K 0.01%
37,616
-1,820
-5% -$29K
ASB icon
877
Associated Banc-Corp
ASB
$5.72B
$616K 0.01%
35,924
-3,871
-10% -$68.9K
ALLE icon
878
Allegion
ALLE
$13.3B
$612K 0.01%
8,812
-936
-10% -$62.2K
GRMN
879
Garmin
GRMN
$46.3B
$612K 0.01%
14,427
+259
+2% +$10.8K
FHI icon
880
Federated Hermes
FHI
$4.35B
$611K 0.01%
21,219
-1,363
-6% -$41.7K
BWA icon
881
BorgWarner
BWA
$13.2B
$609K 0.01%
23,428
-2,375
-9% -$71.8K
TXRH icon
882
Texas Roadhouse
TXRH
$12.5B
$609K 0.01%
13,346
+3,333
+33% +$147K
AMPH icon
883
Amphastar Pharmaceuticals
AMPH
$832M
$608K 0.01%
37,737
+524
+1% +$7.39K
JKHY icon
884
Jack Henry & Associates
JKHY
$10.5B
$605K 0.01%
6,931
-971
-12% -$81.2K
SLM icon
885
SLM Corp
SLM
$4.56B
$604K 0.01%
97,669
-5,301
-5% -$34.5K
PBH icon
886
Prestige Consumer Healthcare
PBH
$2.32B
$603K 0.01%
10,878
+3,269
+43% +$180K
TER icon
887
Teradyne
TER
$58.5B
$602K 0.01%
30,578
-421
-1% -$8.3K
FOLD
888
DELISTED
Amicus Therapeutics
FOLD
$601K 0.01%
110,154
+3,291
+3% +$23K
TRMK icon
889
Trustmark
TRMK
$2.7B
$601K 0.01%
24,169
-1,815
-7% -$43.7K
CIEN icon
890
Ciena
CIEN
$57.7B
$598K 0.01%
31,881
+1,554
+5% +$28.1K
HTS
891
DELISTED
HATTERAS FINANCIAL CORP
HTS
$597K 0.01%
36,384
-3,813
-9% -$60.8K
WKC icon
892
World Kinect Corp
WKC
$1.86B
$595K 0.01%
12,537
-1,924
-13% -$89.6K
GBCI icon
893
Glacier Bancorp
GBCI
$6.59B
$594K 0.01%
22,355
-860
-4% -$22.4K
KDNY
894
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$593K 0.01%
10,487
+923
+10% +$56.1K
SGYP
895
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$593K 0.01%
156,013
+59,611
+62% +$202K
MACK
896
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$593K 0.01%
13,982
+1,265
+10% +$68.9K
IVR icon
897
Invesco Mortgage Capital
IVR
$782M
$592K 0.01%
4,322
-689
-14% -$92.7K
WTM icon
898
White Mountains Insurance
WTM
$5.39B
$592K 0.01%
703
-105
-13% -$85.7K
JACK icon
899
Jack in the Box
JACK
$263M
$590K 0.01%
6,871
-871
-11% -$65.8K
HELE icon
900
Helen of Troy
HELE
$625M
$589K 0.01%
5,726
+1,589
+38% +$160K

Similar funds

ProShare Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, ProShare Advisors held 1,667 positions worth $7.76B, up 6.9% from $7.26B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

ProShare Advisors deployed $366M of net new capital in Q2 2016, opening 74 new positions and adding to 571 existing holdings. Its largest new stake was S&P Global: 454,450 shares worth $48.7M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $10.8M trimmed.

  • ProShare Advisors's largest Q2 2016 buy was S&P Global: 454,450 shares worth $48.7M.
  • ProShare Advisors added most to Healthpeak Properties in Q2 2016, an estimated $16.2M increase.
  • ProShare Advisors's biggest Q2 2016 reduction was Apple, cutting an estimated $10.8M.
  • ProShare Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $36.9M.
  • ProShare Advisors's ten largest holdings make up 16% of its $7.76B portfolio in Q2 2016.
  • ProShare Advisors opened 74 new positions and closed 86 in Q2 2016.
  • ProShare Advisors's portfolio value rose 6.9% quarter-over-quarter to $7.76B.

Based on ProShare Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.